These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35115293)

  • 1. Statins in Hepatitis B or C Patients Is Associated With Reduced Hepatocellular Carcinoma Risk: A Systematic Review and Meta-Analysis.
    Li Z; Li Y; Li X; Zhang L; Zhao N; Du H; Zhou B; Ye Y
    Turk J Gastroenterol; 2022 Feb; 33(2):136-144. PubMed ID: 35115293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins on hepatocellular carcinoma risk in hepatitis B or C patients protocol for a systematic review and meta-analysis.
    Li Z; Li Y; Li X; Zhang L; Zhao N; Du H; Zhou B; Ye Y
    Medicine (Baltimore); 2018 Aug; 97(34):e11950. PubMed ID: 30142817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Meta-analysis of the effects of statins on the risk of chronic liver disease and hepatocellular carcinoma].
    Wei J; Lvy JH; Sun XJ; Wu XR
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jul; 29(7):696-701. PubMed ID: 34371542
    [No Abstract]   [Full Text] [Related]  

  • 4. Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis.
    Li X; Sheng L; Liu L; Hu Y; Chen Y; Lou L
    BMC Gastroenterol; 2020 Apr; 20(1):98. PubMed ID: 32272891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter to the Editor: Statins and Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Huang R; Wang J; Wu W; Yan X; Wu C
    Hepatology; 2020 Jun; 71(6):2173-2174. PubMed ID: 31858599
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of statin treatment with hepatocellular carcinoma risk in end-stage kidney disease patients with chronic viral hepatitis.
    Kim HW; Joo YS; Kang SC; Koh HB; Han SH; Yoo TH; Kang SW; Park JT
    Sci Rep; 2022 Jun; 12(1):10807. PubMed ID: 35752695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection.
    Tsan YT; Lee CH; Ho WC; Lin MH; Wang JD; Chen PC
    J Clin Oncol; 2013 Apr; 31(12):1514-21. PubMed ID: 23509319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.
    Hsiang JC; Wong GL; Tse YK; Wong VW; Yip TC; Chan HL
    J Hepatol; 2015 Nov; 63(5):1190-7. PubMed ID: 26208777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies.
    Morgan RL; Baack B; Smith BD; Yartel A; Pitasi M; Falck-Ytter Y
    Ann Intern Med; 2013 Mar; 158(5 Pt 1):329-37. PubMed ID: 23460056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between hepatitis B virus/hepatitis C virus infection and primary hepatocellular carcinoma risk: A meta-analysis based on Chinese population.
    Li L; Lan X
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C284-C287. PubMed ID: 28230038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
    Simon TG; Duberg AS; Aleman S; Hagstrom H; Nguyen LH; Khalili H; Chung RT; Ludvigsson JF
    Ann Intern Med; 2019 Sep; 171(5):318-327. PubMed ID: 31426090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study.
    Chang FM; Wang YP; Lang HC; Tsai CF; Hou MC; Lee FY; Lu CL
    Hepatology; 2017 Sep; 66(3):896-907. PubMed ID: 28318053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between hepatitis B, hepatitis C and smoking in the development of hepatocellular carcinoma: a systematic review and meta-analysis.
    Shadi Y; Heshmati B; Poorolajal J
    J Public Health (Oxf); 2024 Feb; 46(1):51-60. PubMed ID: 37934962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis.
    Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
    Gastroenterology; 2013 Feb; 144(2):323-332. PubMed ID: 23063971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Goh MJ; Sinn DH; Kim S; Woo SY; Cho H; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Hepatology; 2020 Jun; 71(6):2023-2032. PubMed ID: 31556128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV-associated hepatocellular carcinoma without cirrhosis.
    el-Refaie A; Savage K; Bhattacharya S; Khakoo S; Harrison TJ; el-Batanony M; Soliman el-S ; Nasr S; Mokhtar N; Amer K; Scheuer PJ; Dhillon AP
    J Hepatol; 1996 Mar; 24(3):277-85. PubMed ID: 8778193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.
    Tsan YT; Lee CH; Wang JD; Chen PC
    J Clin Oncol; 2012 Feb; 30(6):623-30. PubMed ID: 22271485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population-based study.
    Choi WM; Kim HJ; Jo AJ; Choi SH; Han S; Ko MJ; Lim YS
    Liver Int; 2021 Nov; 41(11):2777-2785. PubMed ID: 34242482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis.
    del Olmo JA; Serra MA; Rodríguez F; Escudero A; Gilabert S; Rodrigo JM
    J Cancer Res Clin Oncol; 1998; 124(10):560-4. PubMed ID: 9829860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma.
    Wang Y; Wang W; Wang M; Shi J; Jia X; Dang S
    Can J Gastroenterol Hepatol; 2022; 2022():5389044. PubMed ID: 35356132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.